Drug profile · INN
perflutren
LUMINITY
perflutren (LUMINITY) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.
FDA: approved EMA: approved Various (V08) V08DA04
US status approved
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — perflutren
- US status
- approved
- Class
- Various (V08)
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 4
- Data quality
- 0.84
Quick answer
perflutren (LUMINITY) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN perflutren
Brand LUMINITY
Mechanism Diagnostic agent
Therapeutic class Various (V08)
Route INTRAVENOUS
Formulation INJECTABLE
ATC code V08DA04
Mechanism of action
Diagnostic agent
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is perflutren?
perflutren (LUMINITY) is a diagnostic agent. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for perflutren?
LUMINITY is a marketed brand name for perflutren. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of perflutren?
perflutren has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.